Keywords: aronex, ar177, trials, pharmaceuticals, started, phase, oligonucleotide-based

Aronex : AR177 trials

Article | 16 October 1995

Print This

- Aronex Pharmaceuticals has started Phase I trials of AR177, an oligonucleotide-based drug for the management of HIV infection. The drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in